Pierre holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He has previously served at senior positions at ICI-Pharma, Synthelabo, Aventis Sanofi Pasteur, Yamanouchi Pharma, BMS, Drug Abuse Sciences, Schering-Plough and Bio Alliance Pharma.

Currently he is CEO of MRGN Advisors, Chairman of Virometix and Theradiag, Board Member of Vaccitech and Univercells, as well as Regional Partner of Merieux Developpement (France).